Kasturba Medical College, India Wins XV Fujio Cup Quiz in NCRM NICHE 2020
19.10.2020 10:55:00 EEST | Business Wire | Press release
Sufyan Ibrahim and Himanshu Yashavanthi Nagesh of Kasturba Medical College, India, won the prestigious Fujio Cup Quiz (FCQ), an active knowledge gaining academic event of NCRM NICHE 2020, on stem cells and regenerative medicine, in a toughly fought contest among teams representing Monash University, Australia, Birla Institute of Technology (BITS-Pilani), India and Bandung Institute of Technology, Indonesia, who came second. The virtual event had lectures by Prof. Masaharu Seno, Okayama University on induced pluripotent stem cells, Dr Maria Nostro, University of Toronto on pancreatic progenitors for diabetes and Fr Francis Xavier, Loyola College, Chennai in the inter-disciplinary conclave on stress management during Covid-19.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005298/en/
Winners of XV Fujio Cup Quiz, Dr. Ibrahim and Mr. Nagesh of Kasturba Medical College, India, with the 2020- Joyce and James Till Travel Grant Awardee, Dr. Natarajan, a 2013- FCQ Elite. (Graphic: Business Wire)
Regenerative Medicine is a specialty demanding inter-disciplinary interaction, as physical forces like gravity and elasticity, chemically synthesized polymers and nanomaterial scaffolds, provide suitable micro environment to the cells for in vitro culture in the lab, which are transplanted to replace, restore, repair and regenerate tissues to address organ failures. FCQ, a part of NCRM NICHE started in 2006 is conducted in Tokyo, Japan, since 2017 in which young scholars of different specialties of science from all over the world participate, cross several steps of quizzing and assignments to win the trophy. Alumni of top scoring teams of FCQ (FCQ elites) are eligible to nominate candidates to Edogawa NICHE Prize (www.edogawanicheprize.org). The Joyce and James Till Travel Grant (www.j2t2grant.org) instituted in 2018, with a grant by Prof. James Till, 2018 Edogawa NICHE Prize recipient, was awarded this year to Dr. Rupesh Kumar Natarajan, (2013 FCQ elite), now pursuing fellowship in pediatric cardiology, University of Minnesota, USA.
FCQ as an innovation platform, has started attracting multinational companies for collaboration following development of novel solutions like BEES-HAUS for urethral stricture (https://onlinelibrary.wiley.com/doi/full/10.1111/iju.13852), cartilage repair (https://www.sciencedirect.com/science/article/pii/S2352320420300274) and the recently granted patent on microgravity based enhancement of nitric oxide synthesis by blood cells, specially NK cells.
Dr. Shojiro Katoh, (Founder, EELS) congratulated the winners and hopes to invite to Japan beside honoring the 2020 Edogawa NICHE Prize recipient Dr. John Venter in the coming years, by when the Boron Neutron Capture Therapy (BNCT) in Edogawa Hospital (http://bnct-cancer.com/center.php) could be ready to offer treatment to cancer patients from abroad and start research collaboration with overseas institutes. Event information will be updated in: www.ncrmniche.org
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005298/en/
Contact information
Samuel JK Abraham
info@gncorporation.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meraki Capital Launches Tessero Across Six European Markets Following Landmark Hays Acquisition1.9.2026 23:36:00 EEST | Press release
Meraki Capital has launched Tessero,a new European specialist recruitment group created from the six former Hays plc businesses it acquired earlier this summer. Launching simultaneously across Sweden, Denmark, Hungary, Romania, Luxembourg and Czechia, Tessero brings six established recruitment businesses together under one independent European brand, creating an international platform with experienced teams, existing clients and active candidate networks from day one. The launch follows one of the most significant transactions in Meraki Capital’s history and the completion of a major transition programme across all six countries within weeks of the acquisition. 130 employees will now operate under the Tessero brand, with established country leadership teams remaining in place and continuing to lead their respective markets. Gary Elden OBE, CEO of Meraki Capital and Director of Tessero, said: “Tessero launches with something that normally takes years to build: established businesses, ex
SBC Medical to Participate in Several Upcoming Investor Conferences in September 20261.9.2026 20:35:00 EEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced its participation in several upcoming investor conferences in September 2026. SBC Medical will conduct presentations and one-on-one meetings with institutional investors. Below is a summary of the Company’s scheduled participation in upcoming investor conferences: H.C. Wainwright 28th Annual Global Investment Conference Date: September 14 2026 Format: In-person (NY) Registration: https://my.ct.events/register.aspx?meid=cff43623-9e9f-45d4-bbc3-ee19e9c372c1&rpid=a667ca45-171e-4306-98eb-c466e8b7e6c1 ArcStone Kingswood Growth Summit 2026 Date: September 16 2026 Format: In-person (Toronto) Registration:https://www.meetmax.com/sched/event_144037/investor_reg_new.html?attendee_role_id=ARCSTONE_ATTENDEE CLSA 33rd Investors’ Forum 2026 Date: September 21, 2026 Format: In-person (Hong K
Crimson Moon Available Now, Bringing Heavy-Metal Gothic Action to Solo and Co-op Players on PC, PlayStation 5, and Xbox Series X|S1.9.2026 20:00:00 EEST | Press release
ProbablyMonsters, an independent video game company creating original AA games with AAA sensibilities, today launched Crimson Moon on PC via Steam and Epic Game Store, PlayStation 5, and Xbox Series X|S for $19.99 USD. A $29.99 USD Deluxe Edition is also available and includes an exclusive armor set, weapon cosmetic, and upcoming game expansion. Watch the official Crimson Moon launch trailer on YouTube to see the game’s gothic heavy-metal power fantasy, crafted for both solo and co-op players, in action. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901064893/en/ Crimson Moon is a gothic high renaissance action-adventure RPG built around intense, replayable missions that blend brutal precision with deep character progression. Players take on the role of the Nephilim, powerful human-angel hybrids bound to a dark prophecy and charged with reclaiming the besieged city of Gildenarch from a horde of demons, undead, vampires,
Rigaku Launches CT Lab HR160 High-Resolution X-ray CT System1.9.2026 18:00:00 EEST | Press release
Rigaku Corporation, a global solutions partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (Headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), today announced the launch of the CT Lab HR160, a high-resolution X-ray computed tomography (CT) system for battery, semiconductor devices, electronic components, and advanced materials analysis. The system is developed in collaboration with Excillum AB, the global source for X-ray innovation (Headquarters: Stockholm, Sweden; CEO: David Lindblom; “Excillum”). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901074099/en/ Photo: CT Lab HR160 High-Resolution X-ray CT System CT Lab HR160 combines Rigaku’s X-ray CT imaging expertise with Excillum’s NanoTube N3 X-ray source. Operating at up to 160 kV to support a wide range of sample types, the system achieves true 250 nm spatial resolution — an industry-leading level for CT syste
Vivax-Metrotech Partners with Oaktree to Accelerate Strategic Growth1.9.2026 17:00:00 EEST | Press release
Vivax-Metrotech Corporation (“Vivax-Metrotech”), a leading manufacturer of precision locating and inspection devices for utility infrastructure, and Oaktree’s Power Opportunities strategy, today announced a partnership to accelerate Vivax-Metrotech’s growth trajectory and strengthen its leading position. For more than 60 years, Vivax-Metrotech has delivered best-in-class solutions for the utility industry with a focus on underground infrastructure. From its origins in California, the company has expanded across the United States and internationally, developing and supplying locator systems, inspection cameras, and associated digital solutions that help utilities, municipalities, and service providers safely build, maintain, and manage their assets. Today, Vivax-Metrotech is firmly established as a leading player in the U.S. and Global utility locator equipment and inspection device markets. The partnership with Oaktree’s Power Opportunities group will support Vivax-Metrotech’s continue
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom